Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 19 entries
Sorted by: Best Match Show Resources per page
[Pathophysiology and therapeutic aspects of left ventricular "remodeling" in the post-infarct phase].

Acta medica Austriaca

Auer J, Berent R, Eber B.
PMID: 11774772
Acta Med Austriaca. 2001;28(5):117-22. doi: 10.1046/j.1563-2571.2001.01030.x.

Left ventricular remodeling is the process by which ventricular size, shape, and function are regulated by mechanical, neurohormonal, and genetic factors. Remodeling may be physiological and adaptive during normal growth or pathological due to myocardial infarction, cardiomyopathy, hypertension, or...

Cite
Auer J, Berent R, Eber B. Pathophysiologische und therapeutische Aspekte des linksventrikulären "Remodelings" in der Postinfarktphase. [Pathophysiology and therapeutic aspects of left ventricular "remodeling" in the post-infarct phase]. Acta Med Austriaca. 2001;28(5):117-22doi: 10.1046/j.1563-2571.2001.01030.x.
Auer, J., Berent, R., & Eber, B. (2001). Pathophysiologische und therapeutische Aspekte des linksventrikulären "Remodelings" in der Postinfarktphase. [Pathophysiology and therapeutic aspects of left ventricular "remodeling" in the post-infarct phase]. Acta medica Austriaca, 28(5), 117-22. https://doi.org/10.1046/j.1563-2571.2001.01030.x
Auer, J, et al. "Pathophysiologische und therapeutische Aspekte des linksventrikulären "Remodelings" in der Postinfarktphase." [Pathophysiology and therapeutic aspects of left ventricular "remodeling" in the post-infarct phase]. Acta medica Austriaca vol. 28,5 (2001): 117-22. doi: https://doi.org/10.1046/j.1563-2571.2001.01030.x
Auer J, Berent R, Eber B. Pathophysiologische und therapeutische Aspekte des linksventrikulären "Remodelings" in der Postinfarktphase. [Pathophysiology and therapeutic aspects of left ventricular "remodeling" in the post-infarct phase]. Acta Med Austriaca. 2001;28(5):117-22. doi: 10.1046/j.1563-2571.2001.01030.x. German. PMID: 11774772.
Copy Download .nbib Format: NLM
Development of a national pain management competency profile to guide entry-level physiotherapy education in Canada.

Canadian journal of pain = Revue canadienne de la douleur

Augeard N, Bostick G, Miller J, Walton D, Tousignant-Laflamme Y, Hudon A, Bussières A, Cooper L, McNiven N, Thomas A, Singer L, Fishman SM, Bement MH, Hush JM, Sluka KA, Watt-Watson J, Carlesso LC, Dufour S, Fletcher R, Harman K, Hunter J, Ngomo S, Pearson N, Perreault K, Shay B, Stilwell P, Tupper S, Wideman TH.
PMID: 35036823
Can J Pain. 2022 Jan 11;6(1):1-11. doi: 10.1080/24740527.2021.2004103. eCollection 2022.

BACKGROUND: National strategies from North America call for substantive improvements in entry-level pain management education to help reduce the burden of chronic pain. Past work has generated a valuable set of interprofessional pain management competencies to guide the education...

Cite
Augeard N, Bostick G, Miller J, et al. Development of a national pain management competency profile to guide entry-level physiotherapy education in Canada. Can J Pain. 2022;6(1):1-11doi: 10.1080/24740527.2021.2004103.
Augeard, N., Bostick, G., Miller, J., Walton, D., Tousignant-Laflamme, Y., Hudon, A., Bussières, A., Cooper, L., McNiven, N., Thomas, A., Singer, L., Fishman, S. M., Bement, M. H., Hush, J. M., Sluka, K. A., Watt-Watson, J., Carlesso, L. C., Dufour, S., Fletcher, R., Harman, K., Hunter, J., Ngomo, S., Pearson, N., Perreault, K., Shay, B., Stilwell, P., Tupper, S., & Wideman, T. H. (2022). Development of a national pain management competency profile to guide entry-level physiotherapy education in Canada. Canadian journal of pain = Revue canadienne de la douleur, 6(1), 1-11. https://doi.org/10.1080/24740527.2021.2004103
Augeard, Nathan, et al. "Development of a national pain management competency profile to guide entry-level physiotherapy education in Canada." Canadian journal of pain = Revue canadienne de la douleur vol. 6,1 (2022): 1-11. doi: https://doi.org/10.1080/24740527.2021.2004103
Augeard N, Bostick G, Miller J, Walton D, Tousignant-Laflamme Y, Hudon A, Bussières A, Cooper L, McNiven N, Thomas A, Singer L, Fishman SM, Bement MH, Hush JM, Sluka KA, Watt-Watson J, Carlesso LC, Dufour S, Fletcher R, Harman K, Hunter J, Ngomo S, Pearson N, Perreault K, Shay B, Stilwell P, Tupper S, Wideman TH. Development of a national pain management competency profile to guide entry-level physiotherapy education in Canada. Can J Pain. 2022 Jan 11;6(1):1-11. doi: 10.1080/24740527.2021.2004103. eCollection 2022. PMID: 35036823; PMCID: PMC8757473.
Copy Download .nbib Format: NLM
Do catecholamines influence the level of plasma leptin in patients with phaeochromocytoma?.

British journal of biomedical science

Wocial B, Ignatowska-Świtalska H, Berent H, Dutkiewicz-Raczkowska M, Kuczyńska K, Chodakowska J, Feltynowski T, Januszewic W, Szostek M, Cieśla W.
PMID: 27786088
Br J Biomed Sci. 2002 Jan;59(3):141-144. doi: 10.1080/09674845.2002.11783650.

The relationship between plasma leptin and catecholamine concentrations during chronic and acute catecholamine excess is studied. Patients with phaeochromocytoma, divided according to gender, were examined under basal conditions (n=18) and at selected time-points during surgical removal of the tumour...

Cite
Wocial B, Ignatowska-Świtalska H, Berent H, et al. Do catecholamines influence the level of plasma leptin in patients with phaeochromocytoma?. Br J Biomed Sci. 2002;59(3):141-144doi: 10.1080/09674845.2002.11783650.
Wocial, B., Ignatowska-Świtalska, H., Berent, H., Dutkiewicz-Raczkowska, M., Kuczyńska, K., Chodakowska, J., Feltynowski, T., Januszewic, W., Szostek, M., & Cieśla, W. (2002). Do catecholamines influence the level of plasma leptin in patients with phaeochromocytoma?. British journal of biomedical science, 59(3), 141-144. https://doi.org/10.1080/09674845.2002.11783650
Wocial, Bożenna, et al. "Do catecholamines influence the level of plasma leptin in patients with phaeochromocytoma?." British journal of biomedical science vol. 59,3 (2002): 141-144. doi: https://doi.org/10.1080/09674845.2002.11783650
Wocial B, Ignatowska-Świtalska H, Berent H, Dutkiewicz-Raczkowska M, Kuczyńska K, Chodakowska J, Feltynowski T, Januszewic W, Szostek M, Cieśla W. Do catecholamines influence the level of plasma leptin in patients with phaeochromocytoma?. Br J Biomed Sci. 2002 Jan;59(3):141-144. doi: 10.1080/09674845.2002.11783650. PMID: 27786088.
Copy Download .nbib Format: NLM
Complete Revascularization with Multivessel PCI for Myocardial Infarction.

The New England journal of medicine

Auer J, Berent R, Gurtner F.
PMID: 32294355
N Engl J Med. 2020 Apr 16;382(16):1569. doi: 10.1056/NEJMc2000278.

No abstract available.

Cite
Auer J, Berent R, Gurtner F. Complete Revascularization with Multivessel PCI for Myocardial Infarction. N Engl J Med. 2020;382(16):1569doi: 10.1056/NEJMc2000278.
Auer, J., Berent, R., & Gurtner, F. (2020). Complete Revascularization with Multivessel PCI for Myocardial Infarction. The New England journal of medicine, 382(16), 1569. https://doi.org/10.1056/NEJMc2000278
Auer, Johann, et al. "Complete Revascularization with Multivessel PCI for Myocardial Infarction." The New England journal of medicine vol. 382,16 (2020): 1569. doi: https://doi.org/10.1056/NEJMc2000278
Auer J, Berent R, Gurtner F. Complete Revascularization with Multivessel PCI for Myocardial Infarction. N Engl J Med. 2020 Apr 16;382(16):1569. doi: 10.1056/NEJMc2000278. PMID: 32294355.
Copy Download .nbib Format: NLM
The management of high-risk gestational trophoblastic tumours (GTT).

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics

Newlands ES, Bower M, Holden L, Short D, Brock C, Rustin GJS, Begent RHJ, Bagshawe KD.
PMID: 29645230
Int J Gynaecol Obstet. 1998 Apr;60:S65-S70. doi: 10.1016/S0020-7292(98)80007-6.

Between 1979 and 1995 we have treated 272 consecutive women with high-risk (GTT including 121 previously treated patients who were treated with the weekly EMA/CO (etoposide, methotrexate, actinomycin D alternating with cyclophosphamide and vincristine). The median follow-up is 4.5...

Cite
Newlands ES, Bower M, Holden L, et al. The management of high-risk gestational trophoblastic tumours (GTT). Int J Gynaecol Obstet. 1998;60:S65-S70doi: 10.1016/S0020-7292(98)80007-6.
Newlands, E. S., Bower, M., Holden, L., Short, D., Brock, C., Rustin, G. J. S., Begent, R. H. J., & Bagshawe, K. D. (1998). The management of high-risk gestational trophoblastic tumours (GTT). International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 60S65-S70. https://doi.org/10.1016/S0020-7292(98)80007-6
Newlands, E S, et al. "The management of high-risk gestational trophoblastic tumours (GTT)." International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics vol. 60 (1998): S65-S70. doi: https://doi.org/10.1016/S0020-7292(98)80007-6
Newlands ES, Bower M, Holden L, Short D, Brock C, Rustin GJS, Begent RHJ, Bagshawe KD. The management of high-risk gestational trophoblastic tumours (GTT). Int J Gynaecol Obstet. 1998 Apr;60:S65-S70. doi: 10.1016/S0020-7292(98)80007-6. PMID: 29645230.
Copy Download .nbib Format: NLM
Whipple's disease: misdiagnosed as sarcoidosis with further tricuspid valve endocarditis and pulmonary embolism - a case report.

BMJ case reports

Berent R, Auer J, Lassnig E, von Duvillard SP, Crouse SF, Tuppy H, Eber B.
PMID: 21686811
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.07.2008.0441. Epub 2009 Jun 01.

GH Whipple described a 36-year-old physician in 1907 with gradual loss of weight and strength, stools consisting chiefly of neutral fat and fatty acids, indefinite abdominal signs and a peculiar multiple arthritis. The patient died of this progressive illness....

Cite
Berent R, Auer J, Lassnig E, et al. Whipple's disease: misdiagnosed as sarcoidosis with further tricuspid valve endocarditis and pulmonary embolism - a case report. BMJ Case Rep. 2009;2009doi: 10.1136/bcr.07.2008.0441.
Berent, R., Auer, J., Lassnig, E., von Duvillard, S. P., Crouse, S. F., Tuppy, H., & Eber, B. (2009). Whipple's disease: misdiagnosed as sarcoidosis with further tricuspid valve endocarditis and pulmonary embolism - a case report. BMJ case reports, 2009. https://doi.org/10.1136/bcr.07.2008.0441
Berent, Robert, et al. "Whipple's disease: misdiagnosed as sarcoidosis with further tricuspid valve endocarditis and pulmonary embolism - a case report." BMJ case reports vol. 2009 (2009). doi: https://doi.org/10.1136/bcr.07.2008.0441
Berent R, Auer J, Lassnig E, von Duvillard SP, Crouse SF, Tuppy H, Eber B. Whipple's disease: misdiagnosed as sarcoidosis with further tricuspid valve endocarditis and pulmonary embolism - a case report. BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.07.2008.0441. Epub 2009 Jun 01. PMID: 21686811; PMCID: PMC3027720.
Copy Download .nbib Format: NLM
A Phase I Clinical Trial of CHT-25 a 131I-Labeled Chimeric Anti-CD25 Antibody Showing Efficacy in Patients with Refractory Lymphoma.

Clinical cancer research : an official journal of the American Association for Cancer Research

Dancey G, Violet J, Malaroda A, Green AJ, Sharma SK, Francis R, Othman S, Parker S, Buscombe J, Griffin N, Chan PS, Malhotra A, Woodward N, Ramsay A, Ross P, Lister TA, Amlot P, Begent R, McNamara C.
PMID: 20008855
Clin Cancer Res. 2009 Dec 15;15(24):7701-7710. doi: 10.1158/1078-0432.CCR-09-1421.

PURPOSE: There is a need for new treatments for Hodgkin and T-cell lymphoma due to the development of drug resistance in a proportion of patients. This phase I study of radioimmunotherapy used CHT-25, a chimeric antibody to the alpha-chain...

Cite
Dancey G, Violet J, Malaroda A, et al. A Phase I Clinical Trial of CHT-25 a 131I-Labeled Chimeric Anti-CD25 Antibody Showing Efficacy in Patients with Refractory Lymphoma. Clin Cancer Res. 2009;15(24):7701-7710doi: 10.1158/1078-0432.CCR-09-1421.
Dancey, G., Violet, J., Malaroda, A., Green, A. J., Sharma, S. K., Francis, R., Othman, S., Parker, S., Buscombe, J., Griffin, N., Chan, P. S., Malhotra, A., Woodward, N., Ramsay, A., Ross, P., Lister, T. A., Amlot, P., Begent, R., & McNamara, C. (2009). A Phase I Clinical Trial of CHT-25 a 131I-Labeled Chimeric Anti-CD25 Antibody Showing Efficacy in Patients with Refractory Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 15(24), 7701-7710. https://doi.org/10.1158/1078-0432.CCR-09-1421
Dancey, Gairin, et al. "A Phase I Clinical Trial of CHT-25 a 131I-Labeled Chimeric Anti-CD25 Antibody Showing Efficacy in Patients with Refractory Lymphoma." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 15,24 (2009): 7701-7710. doi: https://doi.org/10.1158/1078-0432.CCR-09-1421
Dancey G, Violet J, Malaroda A, Green AJ, Sharma SK, Francis R, Othman S, Parker S, Buscombe J, Griffin N, Chan PS, Malhotra A, Woodward N, Ramsay A, Ross P, Lister TA, Amlot P, Begent R, McNamara C. A Phase I Clinical Trial of CHT-25 a 131I-Labeled Chimeric Anti-CD25 Antibody Showing Efficacy in Patients with Refractory Lymphoma. Clin Cancer Res. 2009 Dec 15;15(24):7701-7710. doi: 10.1158/1078-0432.CCR-09-1421. PMID: 20008855.
Copy Download .nbib Format: NLM
Platelet function in the postprandial period.

Thrombosis journal

Sinzinger H, Berent R.
PMID: 22943574
Thromb J. 2012 Sep 03;10(1):19. doi: 10.1186/1477-9560-10-19.

BACKGROUND: Postprandial hyperlipidemia and hyperglycemia have been related to cardiovascular events. Among different underlying mechanisms platelet activation seems to be responsible too. No comparable data between various tests in normo- vs. hyperlipidemics before and at different time intervals are...

Cite
Sinzinger H, Berent R. Platelet function in the postprandial period. Thromb J. 2012;10(1):19doi: 10.1186/1477-9560-10-19.
Sinzinger, H., & Berent, R. (2012). Platelet function in the postprandial period. Thrombosis journal, 10(1), 19. https://doi.org/10.1186/1477-9560-10-19
Sinzinger, Helmut, and Berent, Robert. "Platelet function in the postprandial period." Thrombosis journal vol. 10,1 (2012): 19. doi: https://doi.org/10.1186/1477-9560-10-19
Sinzinger H, Berent R. Platelet function in the postprandial period. Thromb J. 2012 Sep 03;10(1):19. doi: 10.1186/1477-9560-10-19. PMID: 22943574; PMCID: PMC3502288.
Copy Download .nbib Format: NLM
Working together better for mental health in children and young people during a pandemic: experiences from North Central London during the first wave of COVID-19.

BMJ paediatrics open

Gorny M, Blackstock S, Bhaskaran A, Layther I, Qoba M, Vassar C, Ellis J, Begent J, Forrester J, Goldin J, Hallet Z, Read T, Hodges S, Groszmann M, Hudson LD.
PMID: 34660912
BMJ Paediatr Open. 2021 Oct 07;5(1):e001116. doi: 10.1136/bmjpo-2021-001116. eCollection 2021.

Direct risk from infection from COVID-19 for children and young people (CYP) is low, but impact on services, education and mental health (so-called collateral damage) appears to have been more significant. In North Central London (NCL) during the first...

Cite
Gorny M, Blackstock S, Bhaskaran A, et al. Working together better for mental health in children and young people during a pandemic: experiences from North Central London during the first wave of COVID-19. BMJ Paediatr Open. 2021;5(1):e001116doi: 10.1136/bmjpo-2021-001116.
Gorny, M., Blackstock, S., Bhaskaran, A., Layther, I., Qoba, M., Vassar, C., Ellis, J., Begent, J., Forrester, J., Goldin, J., Hallet, Z., Read, T., Hodges, S., Groszmann, M., & Hudson, L. D. (2021). Working together better for mental health in children and young people during a pandemic: experiences from North Central London during the first wave of COVID-19. BMJ paediatrics open, 5(1), e001116. https://doi.org/10.1136/bmjpo-2021-001116
Gorny, Monika, et al. "Working together better for mental health in children and young people during a pandemic: experiences from North Central London during the first wave of COVID-19." BMJ paediatrics open vol. 5,1 (2021): e001116. doi: https://doi.org/10.1136/bmjpo-2021-001116
Gorny M, Blackstock S, Bhaskaran A, Layther I, Qoba M, Vassar C, Ellis J, Begent J, Forrester J, Goldin J, Hallet Z, Read T, Hodges S, Groszmann M, Hudson LD. Working together better for mental health in children and young people during a pandemic: experiences from North Central London during the first wave of COVID-19. BMJ Paediatr Open. 2021 Oct 07;5(1):e001116. doi: 10.1136/bmjpo-2021-001116. eCollection 2021. PMID: 34660912; PMCID: PMC8507403.
Copy Download .nbib Format: NLM
Cancer informatics in the U.K.: the NCRI informatics initiative.

Cancer informatics

Reddington F, Wilkinson JM, Clark R, Parkinson H, Kerr P, Begent R.
PMID: 19458779
Cancer Inform. 2007 Feb 26;2:389-94.

The arrival of high-throughput technologies in cancer science and medicine has made the possibility for knowledge generation greater than ever before. However, this has brought with it real challenges as researchers struggle to analyse the avalanche of information available...

Cite
Reddington F, Wilkinson JM, Clark R, et al. Cancer informatics in the U.K.: the NCRI informatics initiative. Cancer Inform. 2007;2:389-94
Reddington, F., Wilkinson, J. M., Clark, R., Parkinson, H., Kerr, P., & Begent, R. (2007). Cancer informatics in the U.K.: the NCRI informatics initiative. Cancer informatics, 2389-94.
Reddington, Fiona, et al. "Cancer informatics in the U.K.: the NCRI informatics initiative." Cancer informatics vol. 2 (2007): 389-94.
Reddington F, Wilkinson JM, Clark R, Parkinson H, Kerr P, Begent R. Cancer informatics in the U.K.: the NCRI informatics initiative. Cancer Inform. 2007 Feb 26;2:389-94. PMID: 19458779; PMCID: PMC2675486.
Copy Download .nbib Format: NLM
Guidelines for information about therapy experiments: a proposal on best practice for recording experimental data on cancer therapy.

BMC research notes

González-Beltrán AN, Yong MY, Dancey G, Begent R.
PMID: 22226027
BMC Res Notes. 2012 Jan 06;5:10. doi: 10.1186/1756-0500-5-10.

BACKGROUND: Biology, biomedicine and healthcare have become data-driven enterprises, where scientists and clinicians need to generate, access, validate, interpret and integrate different kinds of experimental and patient-related data. Thus, recording and reporting of data in a systematic and unambiguous...

Cite
González-Beltrán AN, Yong MY, Dancey G, et al. Guidelines for information about therapy experiments: a proposal on best practice for recording experimental data on cancer therapy. BMC Res Notes. 2012;5:10doi: 10.1186/1756-0500-5-10.
González-Beltrán, A. N., Yong, M. Y., Dancey, G., & Begent, R. (2012). Guidelines for information about therapy experiments: a proposal on best practice for recording experimental data on cancer therapy. BMC research notes, 510. https://doi.org/10.1186/1756-0500-5-10
González-Beltrán, Alejandra N, et al. "Guidelines for information about therapy experiments: a proposal on best practice for recording experimental data on cancer therapy." BMC research notes vol. 5 (2012): 10. doi: https://doi.org/10.1186/1756-0500-5-10
González-Beltrán AN, Yong MY, Dancey G, Begent R. Guidelines for information about therapy experiments: a proposal on best practice for recording experimental data on cancer therapy. BMC Res Notes. 2012 Jan 06;5:10. doi: 10.1186/1756-0500-5-10. PMID: 22226027; PMCID: PMC3285520.
Copy Download .nbib Format: NLM
Serum Response Factor Is Essential for Prenatal Gastrointestinal Smooth Muscle Development and Maintenance of Differentiated Phenotype.

Journal of neurogastroenterology and motility

Park C, Lee MY, Park PJ, Ha SE, Berent RM, Fuchs R, Miano JM, Becker LS, Sanders KM, Ro S.
PMID: 26424044
J Neurogastroenterol Motil. 2015 Oct 01;21(4):589-602. doi: 10.5056/jnm15063.

BACKGROUND/AIMS: Smooth muscle cells (SMCs) characteristically express serum response factor (SRF), which regulates their development. The role of SRF in SMC plasticity in the pathophysiological conditions of gastrointestinal (GI) tract is less characterized.METHODS: We generated SMC-specific Srf knockout mice...

Cite
Park C, Lee MY, Park PJ, et al. Serum Response Factor Is Essential for Prenatal Gastrointestinal Smooth Muscle Development and Maintenance of Differentiated Phenotype. J Neurogastroenterol Motil. 2015;21(4):589-602doi: 10.5056/jnm15063.
Park, C., Lee, M. Y., Park, P. J., Ha, S. E., Berent, R. M., Fuchs, R., Miano, J. M., Becker, L. S., Sanders, K. M., & Ro, S. (2015). Serum Response Factor Is Essential for Prenatal Gastrointestinal Smooth Muscle Development and Maintenance of Differentiated Phenotype. Journal of neurogastroenterology and motility, 21(4), 589-602. https://doi.org/10.5056/jnm15063
Park, Chanjae, et al. "Serum Response Factor Is Essential for Prenatal Gastrointestinal Smooth Muscle Development and Maintenance of Differentiated Phenotype." Journal of neurogastroenterology and motility vol. 21,4 (2015): 589-602. doi: https://doi.org/10.5056/jnm15063
Park C, Lee MY, Park PJ, Ha SE, Berent RM, Fuchs R, Miano JM, Becker LS, Sanders KM, Ro S. Serum Response Factor Is Essential for Prenatal Gastrointestinal Smooth Muscle Development and Maintenance of Differentiated Phenotype. J Neurogastroenterol Motil. 2015 Oct 01;21(4):589-602. doi: 10.5056/jnm15063. PMID: 26424044; PMCID: PMC4622142.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 19 entries